NCT03739008View on ClinicalTrials.gov

Reversible Cerebral Vasoconstriction Syndrome With Concomitant Transient Global Amnesia

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

November 8, 2018

Study Completion Date

November 8, 2018

Conditions
Transient Global AmnesiaReversible Vasoconstriction Syndrome
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03739008 - Reversible Cerebral Vasoconstriction Syndrome With Concomitant Transient Global Amnesia | Biotech Hunter | Biotech Hunter